BioSpace News Archive

Bruker (Nasdaq: BRKR) today announced the acquisition of Tornado Spectral Systems Inc.

Aspect Biosystems today announced that Founder and CEO Tamer Mohamed will present at the 42nd Annual J.P. Morgan Healthcare Conference, held January 8-11, 2024 in San Francisco, CA.

Comera Life Sciences Holdings, Inc. announced the closing of a bridge financing with a syndicate of investors.

Pylo Health, a leading provider of remote patient monitoring devices and partner company to Prevounce, announces the launch of two next-generation patient devices: the Pylo 900-LTE blood pressure monitor and the Pylo 200-LTE weight scale.

Perovskite materials are still attracting a lot of interest in solar cell applications. Now, the nanostructures of perovskite materials are being considered as a new laser medium.

BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, is pleased to release transformational images of the recently reported remarkable responder in the Phase 2 study of BriaCell’s Bria-IMT™ combination regimen.

ConcertAI, the leader in oncology predictive and generative AI SaaS Solutions and Real-World Data for healthcare and life sciences, today announced that it will be presenting at the 42nd annual J.P. Morgan Healthcare Conference.

Pressure BioSciences, Inc. announced they are actively pursuing and evaluating multiple artificial intelligence and machine learning prospective partnerships.

OnQuality Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has granted clearance for our OQL025 Investigational New Drug (IND) application, with an indication to treat Epidermal Growth Factor receptor (EGFR) inhibitor-induced acneiform rash, a common toxicity affecting patients treated with EGFR inhibitor therapy.

CatenaBio today announced that it has been selected by the Innovative Genomics Institute, a joint effort between UC Berkeley and UC San Francisco, to present on its proprietary CysTyr® Conjugation platform at the Berkeley Bio Startup Showcase during the J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 9, 2024.